Best Agrolife Ltd. · NSE:BESTAGRO
Best Agrolife — Q3 FY25 Earnings Presentation
21 slides from Best Agrolife's earnings presentation, Feb 14, 2025
Slide 1: Intimation of Press Release and Corporate Presentation
Best Affoli1eLimited CIN : L74l lODLI992PLC116773 14tt February,2O25 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block-G, 2Stt, Floor, P.f. Towers, Bandra - Kurla Complex Dalal Street, Mumbai-400001 Bandra (E), Mumbai-40005 1 SCRIP CODE: 539660 SCRIP ID: BESTAGRO Sub: I
Slide 2: Q3 & 9M FY25 Earnings Release
Best Agrolife Limited B-4, Bhagwan Das Nagar, East Punjabi Bagh New Delhi 110026 Q3 & 9M FY25 Earnings Release Strategic focus on Retail Sales & Patented Products Industry headwinds in key markets combined with muted performance in new markets impacted performance Q3 FY25 Revenue from Operations at
Slide 3: Key Financial Highlights
Best Agrolife Limited B-4, Bhagwan Das Nagar, East Punjabi Bagh New Delhi 110026 While these results are below our expectation, we view them as an opportunity to fine tune our operations for better margins by reducing costs, optimizing operations and building efficiencies. We remain focused on stabi
Slide 4: Business Highlights
Best Agrolife Limited B-4, Bhagwan Das Nagar, East Punjabi Bagh New Delhi 110026 development. The partnership aims to explore new product registrations, joint ventures for factory cooperation, and expand market reach using best practices. • Granted a patent by the African Intellectual Property Organ
Slide 5: Q3 & 9M FY25 Earnings Presentation
Q3 & 9M FY25 Earnings Presentation
Slide 6: Disclaimer
Disclaimer The Presentation is to provide the general background information about the Company’s activities as at the date of the Presentation. The information contained herein is for general information purposes only and based on estimates and should not be considered as a recommendation that any i
Slide 7: Table of Contents
Table of Contents Company Snapshot Management Comment Key Highlights Q3 & 9M FY25 Financial Highlights Way Ahead
Slide 8: Company Snapshot
Company Snapshot 13 th 40 5 Largest Indian Warehouses Patented Products 10,900+ Agrochemical Company* 21 with focus on Branded sales Dealers States 4 27% Manufacturing units 7000 MTPA 494+ 1,150+ 3 Year Revenue CAGR 42% Formulations Technical Capacity Employees registered in India 35,500 KL Formulat
Slide 9: Management Comment
Management Comment “As we reflect on the current state of the agrochemical industry, this season has been challenging climatically and demand wise. Recent cyclonic conditions in southern India have affected the agricultural landscape, particularly in key states like Andhra Pradesh, Telangana, and Ta
Slide 10: Key Highlights
Key Highlights 01 Financial Performance • Revenue for Q3 FY25 decreased to ₹274 crores, primarily due to reduced demand for agrochemical products driven by adverse weather conditions and lower pesticide consumption. • There has been a increase in the branded business but that compensated by the redu
Slide 11: Financial Highlights
Financial Highlights Revenue from operations EBITDA* 315 274 (₹ Crore) (₹ Crore) 19 6% -2% (6) Q3 FY24 Q3 FY25 Q3 FY24 Q3 FY25 PAT EPS Q3 FY24 Q3 FY25 Q3 FY24 Q3 FY25 -7.00 (₹ Crore) (₹ Crore) -2.80 -10.19 -24.00 *EBITDA is calculated excluding other income
Slide 12: Building a Branded Business
Building a Branded Business Branded v/s Institutional Contribution of Patented Sales products in Branded Sales 4% 63% Ronfen Warden Extra 96% 37% 15% 13% Q3 FY24 Q3 FY25 Q3 FY24 Q3 FY25 Branded Institutional Sales Patented Defender 46% 44% 36% 28% 72% 30% 64% 54% 21% 56% 9% 0% FY22 FY23 FY24 9M FY25
Slide 13: Consolidated P&L for Q3 FY25
Consolidated P&L for Q3 FY25 Value (INR Cr) Q3 FY25 Q3 FY24 Y-o-Y Q2 FY25 Revenue from Operations 274 315 (13)% 747 Other Income 0 0 1 Total Revenue 274 315 (13)% 748 Cost of Goods Sold 185 243 494 Employee Benefits Expense 29 25 29 Other Operating Expenses 66 28 76 Total Expenses 280 296 599 EBITDA
Slide 14: Consolidated P&L for 9M FY25
Consolidated P&L for 9M FY25 Value (INR Cr) 9M FY25 9M FY24 FY24 Revenue from Operations 1,554 1,738 1,873 Other Income (2) 2 3 Total Revenue 1,552 1,740 1,876 Cost of Goods Sold 1,083 1,269 1415 Employee Benefits Expense 87 60 82 Other Operating Expenses 182 116 151 Total Expenses 1,352 1,445 1,648
Slide 15: Key Ratios
Key Ratios Debt to Equity (x) Net Debt to Equity (x) 1.06 0.89 0.90 0.97 0.80 0.68 0.67 0.55 FY22 FY23 FY24 9M FY25 FY22 FY23 FY24 9M FY25 Current Ratio (x) ROCE 28% 26% 1.36 1.35 26% 1.32 24% 22% 20% 1.21 15% 18% 13% 16% 14% 12% 10% FY23 FY24 9M FY25 FY22 FY23 FY24 9M FY25 *Formulae: ROCE= EBIT/ Ca
Slide 16: Working Capital Movement
Working Capital Movement 218 212 175 178 167 165 166 152 145 FY23 FY24 9M FY25 Inventory Days Cash coversion days Working capital Days
Slide 17: Experienced Management Team
Experienced Management Team Mr. Vimal Alawadhi Mr. P. N. Karlekar Mr. S. B. V. Rama Prasad Mr. N Surendra Sai Mr. Vikas Jain Managing Director Managing Director Executive Director Head International Business Chief Financial Officer A true visionary and a passionate A chemical Engineer from UDCT- one
Slide 18: Glimpse of Differentiated Products
Glimpse of Differentiated Products CITIGEN VISTARA RONFEN (C T P R) TRICOLOR TOMBO (C T P R) Patented Product (TEMBOTRIONE) Patented Product First to launch in India after Innovator Launched Launched Launched Launched ✓ A single shot solution that controls all ✓ A new generation corn herbicide ✓ Bes
Slide 19: Glimpse of Differentiated Products
Glimpse of Differentiated Products AZARO (PYROXASULFONE) PROPIQUE NEMAGEN DEFENDER (PROPIQUAZAFOP) WARDEN EXTRA ORISULAM 9Patented (3) Registration Product Patented Product Patented Product Patented Product Patented Product Launched Launched Launched Launched Launched Launched ✓ Novel pre-emergence
Slide 20: Patented Products Launch Plan FY25
Patented Products Launch Plan FY25 Patented Product Patented Product CYAZOFAMID + DIMETHOMORPH + DIFENOCONAZOLE HALOXYFOP + IMAZETHAPYR + CHLORIMURON HERBICIDE FUNGICIDE To be launched To be launched ✓ Patent for herbicidal Composition of ✓ Composition of Cyazofamid, Haloxyfop + Imazethapyr + chlori
Slide 21: Thank You
Thank You For queries please contact Adfactors PR Contact US Savli Mangle ir@bestagrolife.com savli.mangle@adfactorspr.com (Investor Relations) Samruddhi Bane Samruddhi.bane@adfactorspr.com Contact: +91 9619624264 DISCLAIMER This presentation includes certain forward looking statements and informati